Partner Jeffrey Fessler Represents Synergy Pharmaceuticals Inc. on $89.8 Million Registered Direct Offering of Common Stock

Press Release – New York, NY – May 6, 2016 – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP is pleased to announce that the Firm has represented Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, on a registered direct offering of 29,948,334 shares of the Company’s common stock at a public offering price per share of $3.00 without an underwriter or placement agent.
Synergy raised $89.8 million in gross proceeds.
The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Stephen A. Cohen.
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.15 Million Private Placement Offering of SciSparc Ltd. - March 5, 2021
- Sichenzia Ross Ference LLP Represents Splash Beverage Group, Inc. in $4 Million Private Placement - March 5, 2021
- Sichenzia Ross Ference LLP Represents Borqs Technologies, Inc. in $20 Million Private Placement - March 3, 2021